New Combination Strategy for Metastatic RCC | Checkmate-214 Data for Nivolumab & Ipilimumab

Aly-Khan A. Lalani, MD, FRCPC Juravinski Cancer Centre, explains New Combination Strategy for Metastatic RCC | Checkmate-214 Data for Nivolumab & Ipilimumab at Annual Meeting 2018